Efficacy and immunogenicity of a single dose of human papillomavirus vaccine compared to no vaccination or standard three and two-dose vaccination regimens: A systematic review of evidence from clinical trials
Open Access
- 20 December 2019
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 38 (6), 1302-1314
- https://doi.org/10.1016/j.vaccine.2019.12.017
Abstract
No abstract availableKeywords
Funding Information
- PATH
- LSHTM
- NCI
- UBC
- CHU
- CDC
This publication has 33 references indexed in Scilit:
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in WomenThe New England Journal of Medicine, 2015
- Immunogenicity of bivalent HPV vaccine among partially vaccinated young adolescent girls in UgandaVaccine, 2014
- Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV typesBritish Journal of Cancer, 2014
- Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine TrialCancer Prevention Research, 2013
- Global Burden of Human Papillomavirus and Related DiseasesVaccine, 2012
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 VaccineJNCI Journal of the National Cancer Institute, 2011
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa RicaVaccine, 2008